Work

FDA Approves Ibrexafungerp (Brexafemme) for the Treatment of Vulvovaginal Candidiasis

Year: 2021

Type: article

Source: Journal watch

DOI: 10.1056/nejm-jw.na53719

Author: George Sakoulas

Language: French

Topic: Antifungal resistance and susceptibility

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3180176197

FWCI: 0.079

Cites:

Cited by: 1

Related to: 10